As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

Canada’s cannabis market saw another flashy acquisition get confirmed this week as HEXO (NYSE:HEXO,TSX:HEXO) agreed to buy Zenabis Global (TSX:ZENA) in a C$235 million all-share deal.

Additionally, a cannabis retail operator announced its intention to list its shares on the NASDAQ.

Keep reading... Show less

A longstanding executive for a foundational publicly traded Canadian cannabis firm is set to return to the space as CEO of a company looking to shift strategies.

Terry Booth is expected to become the official new leading executive at Australis Capital (CSE:AUSA,OTCQB:AUSAF) pending an acquisition deal set to close before February 22.

Keep reading... Show less

After successfully becoming the first company to develop proprietary knowledge to control the production of cannabis cells in liquid media, BioHarvest Sciences (CSE:BHSC) CEO Ilan Sobel shares his thoughts on how the company is embarking on a journey to take a space in the cannabis market while making a fundamental difference to the overall health and wellness of the populations of the world.

“Our number one focus every day has to be around driving human utility value, how we make the world better every single day for the consumers through the use of our products,” Ilan said.

BioHarvest’s ground-breaking milestone leverages its patented BioFarming technology, independent of any specific cannabis strain genetics. This optimization of the trichome’s growth is a key condition and major enabler for the consistent, cost-efficient and sustainable production of plant-cell-based cannabis and cannabinoids.

The company takes pride in its breakthrough biotech technology, which allows it to deliver on the health and wellness needs of consumers and acquire that strong market momentum in 2021.

For more from Ilan Sobel, watch the full interview above.

Keep reading... Show less

Cannabis stocks go for a bumpy ride after becoming the most recent target of coordinated Reddit open market moves.

A stock market researcher issued a new report highlighting the recent changes in short selling for the cannabis space.

Keep reading... Show less

One of the biggest names in cannabis-based novel medicine announced this week that it will be acquired by a fellow pharmaceutical player.

Also this week, new numbers show that Canadian sales of legal cannabis are overtaking sales of unregulated products in the country.

Keep reading... Show less